BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
26 hedge funds and large institutions have $9.18M invested in Baudax Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-12
Holders Change %
-31.58%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
8
Reduced
9
Closed
13
Calls
$272K
Puts
$467K
Net Calls
-$195K
Net Calls Change
-$3.97M
Top Buyers
Top Sellers
1 |
CCM
Corsair Capital Management
New York
|
-$1.21M |
2 |
NRC
North Run Capital
Boston,
Massachusetts
|
-$395K |
3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$202K |
4 |
Jane Street
New York
|
-$164K |
5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$112K |